Drug Trial Radar · NCT06475846
A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults
Last checked: Nov 19, 2026Latest source record: Jan 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
235
Actual
Start
Jun 25, 2024
Primary completion
Oct 29, 2024
Study completion Oct 29, 2024
Sponsor
- Lead sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is being conducted to evaluate the efficacy, and safety of HRS5580 for preventing of postoperative nausea and vomiting in adults. To explore the reasonable dosage of HRS5580 for postoperative nausea and vomiting.
Conditions
- Preventing of Postoperative Nausea and Vomiting in Adults
Interventions
HRS5580Drug
HRS5580; low dose
HRS5580Drug
HRS5580; middle dose
HRS5580Drug
HRS5580; middle dose
OndansetronDrug
Ondansetron
blank preparationDrug
blank preparation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- No vomiting rate within 72 hours after extubationTime frame: at 72 hours after extubation
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Third Xiangya Hospital of Central South University
Changsha, Hu'nan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.